Skip to main content
. 2020 Aug 24;8(1):e001328. doi: 10.1136/bmjdrc-2020-001328

Table 2.

Characteristics of study population stratified by racial and ethnic groups

White
(n=72 219)
African American
(n=13 279)
Hispanic
(n=3039)
Native American
(n=611)
Other
(n=3781)
Demographics
Age, mean (SD) 72.6 (11.5) 68.6 (12.8) 69.7 (14.1) 66.6 (12.4) 71.7 (11.4)
Age group
 <65 years 16 140 (22.4) 4907 (37.0) 992 (32.6) 250 (40.9) 923 (24.4)
 ≥65 years 56 079 (77.7) 8372 (63.1) 3264 (67.4) 361 (59.1) 2858 (75.6)
Gender
 Male 33 673 (46.6) 5310 (40.0) 1386 (45.6) 269 (44.0) 1870 (49.5)
 Female 38 546 (53.4) 7969 (60.0) 1653 (54.4) 342 (56.0) 1911 (50.5)
Socioeconomic factor
 Disability 20 204 (28.0) 6188 (46.6) 1155 (38.0) 313 (51.2) 823 (21.8)
 Low income subsidy 42 543 (58.9) 10 377 (78.2) 2741 (90.2) 506 (82.8) 2896 (76.6)
Country residence
 Metropolitan 57 807 (80.0) 11 717 (88.2) 2840 (93.5) 298 (48.8) 3586 (94.8)
 Non-metropolitan 14 312 (19.8) 1542 (11.6) 188 (6.2) 309 (50.9) 183 (4.9)
 Unknown 100 (0.1) 20 (0.2) 11 (0.4) 4 (0.7) 12 (0.3)
Median income
 Q1 17 480 (24.2) 4267 (32.1) 996 (32.8) 287 (47.0) 323 (8.5)
 Q2 18 744 (26.0) 3279 (24.7) 472 (15.5) 180 (29.5) 668 (17.7)
 Q3 17 481 (24.2) 3142 (23.7) 985 (32.4) 80 (13.1) 1375 (36.4)
 Q4 18 514 (25.6) 2591 (19.5) 586 (19.3) 64 (10.5) 1415 (37.4)
Poverty
 <20% 58 894 (81.6) 8752 (65.9) 1891 (62.2) 349 (57.1) 3251 (86.0)
 ≥20% 13 325 (18.5) 4527 (34.1) 1148 (37.8) 262 (42.9) 530 (14.0)
Low income subsidy 42 543 (58.9) 10 377 (78.2) 2741 (90.2) 506 (82.8) 2896 (76.6)
Medical history
 ESRD 1191 (1.7) 843 (6.4) 177 (5.8) 61 (10) 176 (4.7)
 PAD 38 105 (52.8) 7943 (59.8) 1658 (54.6) 352 (57.6) 1716 (45.4)
 Insulin 10 328 (14.3) 2835 (21.4) 738 (24.3) 157 (25.7) 614 (16.2)
 Elixhauser comorbidity index, mean (SD) (range 0–29) 3.8 (2.8) 4.4 (3.2) 3.9 (2.8) 4.0 (3.0) 3.5 (2.7)
 DCSI, mean (SD) (range 0–13) 2.1 (1.3) 2.4 (1.4) 2.3 (1.4) 2.2 (1.5) 2.1 (1.3)
Index diagnosis
 DFU 13 726 (19.0) 1963 (14.8) 319 (10.5) 119 (19.5) 496 (13.1)
 DFI 58 493 (81.0) 11 316 (85.2) 2720 (89.5) 492 (80.5) 3285 (86.9)
Specialty for DFU/DFI diagnosis
 Primary care 8367 (11.6) 1406 (10.6) 389 (12.8) 95 (15.6) 549 (14.5)
 Podiatry 16 405 (22.7) 2748 (20.7) 628 (20.7) 69 (11.3) 775 (20.5)
 Specialist 47 447 (65.7) 9125 (68.7) 2022 (66.5) 447 (73.2) 2457 (65)
Place of DFU/DFI diagnosis
 Hospital 4098 (5.7) 1041 (7.8) 174 (5.7) 57 (9.3) 172 (4.6)
 Outpatient 10 632 (14.7) 1797 (13.5) 328 (10.8) 253 (41.4) 370 (9.8)
 ED 809 (1.1) 213 (1.6) 44 (1.5) 17 (2.8) 42 (1.1)
 Home health agency 476 (0.7) 85 (0.6) 26 (0.9) 1 (0.2) 18 (0.5)
 Skilled nursing facility 1628 (2.3) 363 (2.7) 51 (1.7) 8 (1.3) 82 (2.2)
 Other 54 576 (75.6) 9780 (73.7) 2416 (79.5) 275 (45.0) 3097 (81.9)
Early PCP follow-up (30 days after diagnosis) 35 242 (48.8) 6742 (50.8) 1523 (50.1) 328 (53.7) 1892 (50.0)
Revascularization within 12 months 5499 (7.6) 1899 (14.3) 345 (11.4) 101 (16.5) 334 (8.8)
Healthcare utilization after DFU/DFI diagnosis
 ED visits per person, mean (SD) 0.02 (0.2) 0.03 (0.2) 0.03 (0.2) 0.03 (0.2) 0.01 (0.1)
 Outpatient visits per person, mean (SD) 1.59 2.25 2.39 2.23 1
 Inpatient hospital stay per person, mean (SD) 13.93 (27.6) 19.26 (28.7) 15.4 (21.6) 15.65 (26.95) 15.65 (27.0)
 Number of major amputations 1068 (1.5) 507 (3.8) 64 (2.1) 31 (5.1) 56 (1.5)
 Unadjusted risks of major amputation Reference HR=2.65, 95% CI=2.38 to 2.94, p<0.0001 HR=1.41, 95% CI=1.10 to 1.82, p=0.0007 HR=3.62, 95% CI=2.53 to 5.17, p<0.0001 HR-1.00, 95% CI=0.77 to 1.31, p=0.98

Values are reported as number (%) unless otherwise specified.

DCSI, Diabetes Complications Severity Index; DFI, diabetic foot infection; DFU, diabetic foot ulcer; ED, emergency room; ESRD, end-stage renal disease; PAD, peripheral artery disease; PCP, primary care physician; Q, quartile.